Edition:
United States

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

465.00SEK
20 Aug 2018
Change (% chg)

25.00kr (+5.68%)
Prev Close
440.00kr
Open
453.00kr
Day's High
475.00kr
Day's Low
453.00kr
Volume
80,742
Avg. Vol
23,882
52-wk High
475.00kr
52-wk Low
278.50kr

Chart for

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.79
Market Cap(Mil.): kr7,302.15
Shares Outstanding(Mil.): 16.60
Dividend: 4.31
Yield (%): 2.05

Financials

  BIOGb.ST Industry Sector
P/E (TTM): 38.74 20.64 37.19
EPS (TTM): 11.36 -- --
ROI: 49.44 10.51 59.18
ROE: 50.06 14.35 71.73

BRIEF-Biogaia Q1 operating profit roughly unchanged yr/yr

* BIOGAIA AB Q1 OPERATING PROFIT AMOUNTED TO SEK 56.2 MILLION (56.1) Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Apr 25 2018

BRIEF-Biogaia increases stake in MetaboGen to 62 pct

* Has decided to acquire additional shares in the associated company MetaboGen AB and is now investing SEK 11.7 million in shares in the company.

Apr 06 2018

BRIEF-Biogaia partners with Dr Reddy's for India launch of protectis drops

* BIOGAIA HAS ENTERED INTO A PARTNERSHIP WITH DR. REDDY’S LABORATORIES FOR THE MARKETING AND DISTRIBUTION OF BIOGAIA PROTECTIS DROPS IN THE INDIAN MARKET

Mar 23 2018

Earnings vs. Estimates